black box warning for glp 1 GLP-1 Agonist Thyroid Cancer: A black box
Description
Products with undeclared active substances are particularly risky
To better understand these connections and evaluate GLP-1RAs potential as a therapeutic approach for treating skeletal frailty in diabetes patients, especially the elderly more extensive long-term research is required (65)
Thats the work we do here every day
K.SinghA.de AraujoA.McDougleM.VergaraM.et al (2021)
Semaglutide in Reducing Body Weight in Humans
2009;339:b2700
